SEC Form 4 · accession 0001209191-19-008148
FIVE PRIME THERAPEUTICS INC · FPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Helen Louise Collins
Officer — SVP and Chief Medical Officer
Period of report
Feb 5, 2019
Accepted (ET)
Feb 7, 2019 · 5:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175505
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 5, 2019 | F | 3,196 | $11.43 | D | 30,971 | D |
Table II — derivative securities
No Table II lines on this filing.